GDK Biotech issued the first batch of flu vaccine approvals in 2025
On September 1st, the China Food and Drug Administration Research Institute announced that GDK Biotech's first batch of influenza vaccines for 2025 has been issued
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments